Inventor
Jonathan Harry DAVIS
Inventor
US
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
C07KPeptides25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations19%
C12NMicroorganisms or enzymes19%
Y02ATechnologies for adaptation to climate change13%
PatentTitleYear
12,312,418Orthogonal mutations for heterodimerization202512,202,872Interleukin-2/interleukin-2 receptor alpha fusion proteins and methods of use202511,535,868Miniaturized dystrophins having spectrin fusion domains and uses thereof202211,359,000Interleukin-2/Interleukin-2 receptor alpha fusion proteins and methods of use2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to BRISTOL MYERS SQUIBB CO (3)· patent assignee history
2022–2025Based in US· patent location history
2025Patents assigned to INVENRA INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BRISTOL MYERS SQUIBB CO | 3 | 2022–2025 |
| INVENRA INC | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 4 | 2022–2025 |